We are live on ! Find out more
GEN

Genesis Healthcare, Inc.
GEN

Delisted

GEN was delisted on the 25th of March, 2021.

77 hedge funds and large institutions have $49.5M invested in Genesis Healthcare, Inc. in 2019 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 21 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more capital invested

Capital invested by funds: $40.2M → $49.5M (+$9.3M)

22% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 9

3% more funds holding

Funds holding: 7577 (+2)

5% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 21

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
77
Holders Change
+2
Holders Change %
+2.67%
% of All Funds
1.67%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
11
Increased
22
Reduced
21
Closed
9
Calls
$50K
Puts
Net Calls
+$50K
Net Calls Change
-$1.11M
Name Holding Trade Value Shares
Change
Change in
Stake
VCM
1
V3 Capital Management
Texas
$5.99M +$881K +594,131 +17%
FWC
2
First Washington Corp
Washington
$5M +$180K +121,280 +4%
Renaissance Technologies
3
Renaissance Technologies
New York
$4.85M +$464K +313,000 +10%
BlackRock
4
BlackRock
New York
$4.52M -$166K -111,895 -3%
CPA
5
Columbia Pacific Advisors
Washington
$4.22M -$443K -298,710 -9%
Vanguard Group
6
Vanguard Group
Pennsylvania
$3.41M +$397K +267,522 +13%
Acadian Asset Management
7
Acadian Asset Management
Massachusetts
$2.83M +$410K +276,436 +16%
Chevy Chase Trust
8
Chevy Chase Trust
Maryland
$2.6M
GWS
9
Glassman Wealth Services
Virginia
$1.44M
BCM
10
Bridgeway Capital Management
Texas
$1.42M +$16K +10,800 +1%
State Street
11
State Street
Massachusetts
$1.38M -$380K -256,220 -21%
PGCM
12
Prescott Group Capital Management
Oklahoma
$1.34M
PAM
13
Panagora Asset Management
Massachusetts
$1.34M +$240K +162,048 +21%
TCIM
14
TIAA CREF Investment Management
New York
$975K +$165K +111,100 +20%
Millennium Management
15
Millennium Management
New York
$963K +$197K +132,631 +25%
Northern Trust
16
Northern Trust
Illinois
$944K -$1.63K -1,102 -0.2%
HighTower Advisors
17
HighTower Advisors
Illinois
$754K
Geode Capital Management
18
Geode Capital Management
Massachusetts
$719K +$36K +24,311 +5%
California Public Employees Retirement System
19
California Public Employees Retirement System
California
$481K -$73.3K -49,434 -13%
JP Morgan Chase
20
JP Morgan Chase
New York
$475K -$93.8K -63,276 -16%
Invesco
21
Invesco
Georgia
$278K +$287K +193,384 New
Morgan Stanley
22
Morgan Stanley
New York
$252K -$182K -122,970 -41%
Bank of New York Mellon
23
Bank of New York Mellon
New York
$241K -$955 -644 -0.4%
DWT
24
Dorsey & Whitney Trust
South Dakota
$222K +$67.3K +45,380 +42%
Connor, Clark & Lunn Investment Management (CC&L)
25
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$215K -$19.4K -13,100 -8%

GEN Hedge Fund Activity: Q1 2019 in Review

77 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Genesis Healthcare, Inc. (GEN) for Q1 2019, worth a combined $49.5M — up 23% from $40.2M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new GEN positions and 9 closed out — a net gain of 2 holders — while 22 added to existing stakes and 21 trimmed.

The largest buyer was V3 Capital Management, adding an estimated $881K. The largest seller was D.E. Shaw & Co, cutting an estimated $805K.

  • 77 institutional investors held Genesis Healthcare, Inc. (GEN) as of Q1 2019, up from 75 in Q4 2018.
  • Funds reported $49.5M of Genesis Healthcare, Inc. stock for Q1 2019, up 23% quarter-over-quarter.
  • 11 funds opened new Genesis Healthcare, Inc. positions in Q1 2019 and 9 closed out, a net change of +2 holders.
  • The largest Genesis Healthcare, Inc. buyer in Q1 2019 was V3 Capital Management, an estimated $881K added.
  • The largest Genesis Healthcare, Inc. seller in Q1 2019 was D.E. Shaw & Co, an estimated $805K sold.

Based on aggregated 13F filings for Q1 2019.